Recombinant Anti-human FRMD4A Intrabody [Tat]

Recombinant anti-FRMD4A intrabody in fusion with HIV Tat works within cells to direct against human FRMD4A, expressed in CHO cells. The intrabody can be used in therapeutic methods for treating proliferative disorders, including squamous cell carcinoma (SCC).
Supplier Creative Biolabs
Product # IAB-B059(T)
Pricing Inquiry
Host human
Target FRMD4A
Species Reactivity human
Type scFv-Tat
Applications Used for immunoassay techniques such as: Flow Cytometry; Immunofluorescence; Functional studies
Storage Store at – 20 or -70°C upon receipt. Divide antibody into aliquots prior usage and avoid multiple freeze-thaw cycles.
Feedback